Objective: To identify the risk factors contributing to intraventricular hemorrhage (IVH) in extremely low birth weight infants during early postnatal life, after appropriate matching for gestational age (GA) and birth body weight (BBW).
Introduction
Intraventricular hemorrhage (IVH) is a common neonatal morbidity among extremely premature infants and leads to adverse neurodevelopmental sequelae. Although its incidence has declined during recent decades, IVH remains a significant risk factor for mortality and morbidity among extremely premature infants. [1] [2] [3] [4] Approximately 90% of IVH occurs within the first three postnatal days and its incidence is inversely related to gestational age (GA) and birth body weight (BBW). 4, 5 Numerous risk factors are related to IVH, such as male gender, premature rupture of membranes, mode of delivery, postnatal resuscitation, early onset sepsis, respiratory distress syndrome, pneumothorax, hypoxemia, hypo-and hyper-carbia. 5 Besides, Gawlowski et al. reported that IVHs were more common among infants with hypernatremia. 6 As most of the previous studies were lacking in appropriate matching controls for GA and BBW, they may simply have investigated a population of higher risks and the results may be confounded by both variables. We performed a case-control study to minimize the confounding effects of GA and BBW, and to determine the potential risk factors for severe IVH.
Methods
This retrospective, case-control study was conducted in the neonatal intensive care unit (NICU) at Chang Gung Children's Hospital, and used the NICU database. The database recorded all infants' medical information from admission to the NICU until discharge. From January 2002 to June 2009 preterm infants with a BBW p1000 g, a GA p26 weeks and diagnosed with IVH grades III/IV were identified from our database as the study group (IVH group). Routine cranial ultrasound was performed by a pediatric neurologist within the first 3 days of life in the NICU. Grading of IVH was made according to the Papile classification system, 7 and grades III or IV IVH were defined as severe IVH. We excluded infants with brain malformations, dysmorphic features or congenital anomalies suggestive of genetic syndromes, metabolic disorders and chromosomal abnormalities, or confirmed central nervous system infections within the first 3 days of life. The first compatible infant with a birthday closest to the study infant, a normal cranial ultrasound and closely matched for GA ( ± 1 week) and BBW (±100 g) was selected from the cohort for each case to form the control group. The GA was determined from the last menstrual period.
The medical records of the infants were reviewed to collect prenatal and postnatal variables. Prenatal variables included antenatal steroids, maternal parity, maternal fever, maternal chorioamnionitis, preeclampsia, antepartum hemorrhage, placenta previa and preterm premature rupture of the membranes (PPROMs). Intrapartum and labor variables included the mode of delivery, GA, BBW, first-and fifth-min Apgar scores and intubation and resuscitation in the delivery room. Postnatal factors included the use of inotropes, respiratory distress syndrome, pneumothorax, sepsis, patent ductus arteriosus and treatment for patent ductus arteriosus. Clinical outcomes, such as mortality, periventricular leukomalacia and post-hemorrhagic hydrocephalus were also collected.
According to our NICU routine protocol, the body weight (BW) of each patient was recorded daily and as required. The input and output (I/O) of each neonate was recorded every 8 h, and DI/O was defined as the difference between the highest and lowest daily I/O within the first 3 days of life. Intravenous fluid was given with 5% glucose water (D5W) at a rate of 80 to 100 ml kg À1 per day on the first day. Electrolyte data of these infants were collected at birth, 12 h of age, 24 h of age and repeated as needed. Serum sodium levels at birth, as well as the highest and lowest levels within the first 3 days of life, for each patient were documented. Changes in serum sodium levels were defined as the differences between the highest and lowest serum sodium levels observed during the first 3 days of life.
The values for hemoglobin, platelets, prothrombin time and activated partial thrombin time were recorded, and the difference between the highest and lowest values was defined as DHb, Dplatelet, DPT (prothrombin time) and DaPTT (activated partial thromboplastin time), respectively. Arterial blood gas was analyzed, and the difference between the highest and lowest values of pH, PaCO 2 and PaO 2 was defined as DpH, DPaCO 2 and DPaO 2 , respectively.
In the current study, antenatal steroids were defined as at least one dose of either betamethasone or dexamethasone given prenatally. Maternal fever was defined as an ear temperature >38 1C within 72 h before delivery. Chorioamnionitis was diagnosed clinically by an obstetrician and recorded in the maternal records with at least one of the following: maternal fever >38 1C, maternal leukocytosis, uterus tenderness, foul-smelling amniotic fluid and positive amniotic fluid culture. The use of inotropes was defined as either the use of dopamine, dobutamine, milrinone or epinephrine within the first 3 days of life. Respiratory distress syndrome was diagnosed on the basis of the requirement of a mechanical ventilator or surfactant together with the radiographic findings. Pneumothorax was diagnosed by a chest X-ray that may require a thoracocentesis or chest tube insertion. Sepsis was defined if the clinical symptoms occurred within the first 3 days of life with a positive blood culture. Periventricular leukomalacia was defined as parenchymal echo densities/lucencies around the ventricles, documented using cranial ultrasound scans after 21 days of life. Post-hemorrhagic hydrocephalus was diagnosed using a cranial ultrasound or computed tomography with evidence of ventricular dilatation.
Statistical analysis was performed using SPSS software version 15.0. Categorical data were analyzed using the standard w 2 -test or Fisher's exact test, where appropriate. Continuous data were analyzed using the independent t-test for between-group comparisons. Statistical significance was defined as Pp0.05. Significant variables from the univariate analysis were used in the stepwise logistic regression model. Independent variables were considered to be significant and associated with severe IVH if Pp0.05. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were computed for all outcomes.
Results
Between January 2002 and June 2009, 347 preterm infants with a BBW p1000 g and a GA p26 weeks were admitted to our NICU; 37 cases developed severe IVH within the first 3 days of life. One case was excluded because of inadequate medical records and clinical data; hence, 36 neonates were enrolled as the study group. The incidence of severe IVH was 10.7% (37/347) among all infants with a BBW p1000 g and a GA p26 weeks. Thirteen (13/37; 35.1%) infants with severe IVH developed post-hemorrhagic hydrocephalus, and two (2/13; 15.4%) of these infants required a ventriculoperitoneal shunt. The mortality rate was 47.2% (17/36) in the IVH group and 13.9% (5/36) in the control group. In the IVH group, eight preterm infants died within the first 3 days of life, but none of them died within the first 24 h of life, and all deaths were related to intractable seizure, IVH or hypovolemic shock. None of the patients in the control group died within the first 3 days. Two patients in the IVH group had periventricular leukomalacia corresponding to an incidence of 5.4%. In contrast, none of patients in the control group developed periventricular leukomalacia.
Demographic data, prenatal and intrapartum factors There was no difference in BBW and GA between the IVH and control groups.
Male infants had an increased risk of developing severe IVH (77.8 vs 50.0%; P ¼ 0.014) ( Table 1) . Vaginal delivery, resuscitation in the delivery room and a lower fifth-min Apgar score were also associated with severe IVH (Table 2) . Preterm premature rupture of the membrane and prenatal steroid were more common in the control group (55.6 and 63.9%, respectively) than in the IVH group (33.3 and 47.2%, respectively), but not significantly so (P ¼ 0.058 and P ¼ 0.236, respectively). The incidence of clinical chorioamnionitis was not significantly different between both groups (11.1 vs 13.9%; P ¼ 1.0).
Postnatal clinical factors
The postnatal clinical factors are shown in Table 3 . All of the infants had respiratory distress syndrome and required surfactant therapy. Pneumothorax (16.7 vs 2.8%; P ¼ 0.107) and the use of inotropes at birth (91.7 vs 75.0%; P ¼ 0.058) were more common in the IVH group, but not significantly so. Two patients in the IVH group had Escherichia coli and Streptococcus viridian sepsis within the first 3 days of life. Both groups had a similar rate of patent ductus arteriosus and surgical ligation.
Hematological factors
The hematological factors are shown in Table 4 . The hemoglobin levels at birth were significantly lower in the IVH group (P ¼ 0.037). The IVH group also had significantly lower hemoglobin (P<0.001) and platelet (P<0.001) counts within the first 3 days of life. In addition, the changes in hemoglobin (P<0.001) and platelet (P<0.001) counts were significantly larger in the IVH group. There was no difference in the levels of prothrombin time or activated partial thromboplastin time at birth between both groups.
Blood-gas analysis during the first 3 days of life
The arterial blood gas parameters are listed in Table 4 . Both groups had similar pH and PaO 2 levels at birth. Infants in the IVH group tended to have higher PaCO 2 levels at birth (P ¼ 0.057); besides, infants in the IVH group had significantly greater fluctuations in their CO 2 (P ¼ 0.001) and pH (P<0.001) levels.
Fluid and electrolyte status within the first 3 days of life Table 5 depicts the fluid and electrolyte data from both groups. The total amount of fluid, I/O and BW loss were similar between both groups. Infants in the IVH group had significantly higher sodium levels at birth (146.8 vs 142. 9 meq l À1 ; P ¼ 0.027). The highest sodium level was 162.6 meq l À1 in the IVH group, compared with 148.8 meq l À1 in the control group (P<0.001). The fluctuation of the serum sodium levels was more prominent in the IVH group (17.3 vs 6.2 meq l À1 ; P<0.001). Infants with changes in their serum sodium levels of more than 13 meq l À1 had an increased risk of developing severe IVH (P<0.001). There were no significant differences in the occurrence of hyperglycemia or hypoglycemia between both groups. After using univariate analysis, the significant parameters were pooled together to exclude the confounding factors by performing multivariate logistic regression analysis. The results showed that DNa >13 meq l À1 (adjusted OR 12.4, 95% CI 1.9 to 82.7), vaginal delivery (adjusted OR 7, 95% CI 1.5 to 32.8), male sex (adjusted OR 13.6, 95% CI 2 to 90) and DHb at birth (adjusted OR 1.7, 95% CI 1.2 to 2.4) were strongly associated with the development of severe IVH.
Discussion
Hypernatremia is common among preterm infants. 8 The majority of hypernatremia in preterm infants is caused by dehydration rather than excess sodium intake. [9] [10] [11] [12] In preterm infants with a GA <26 weeks, insensible water loss could be as high as 200 ml kg À1 per day; 13 besides, early diuresis and negative water balance can lead to isotonic dehydration of the extracellular fluid compartment and subsequent postnatal weight loss during the first few days of life. An initial loss of 10 to 15% of body weight is common among very low birth weight infants, but serum sodium concentrations remain within the normal range. 9 Using a case-matched design, the GA and BBW were controlled in the current study. The net BW loss was less than 10% of the BBW in both groups, and there was no difference in the amount of fluid and scale of BW change during the first 3 postnatal days. Taken together, the phenomenon of hypernatremia in the severe IVH group could not be explained solely by dehydration.
Hypernatremia is related to a high mortality rate in patients with subarachnoid hemorrhage. Intracerebral hemorrhage results in the destruction of the hypothalamic nuclei, a reduction in the secretion of antidiuretic hormones, and hypernatremia; 14 hence, hypernatremia in preterm infants with severe IVH may be the result of severe brain damage. 14, 15 On the other hand, hypernatremia had been shown to cause brain shrinkage and resultant vascular rupture with cerebral bleeding and IVH. 16, 17 In response to brain shrinkage induced by hypernatremia, the human brain initiates an adaptive response to form idiogenic osmoles that increase intracellular sodium concentrations and restore lost water. [18] [19] [20] This phenomenon increases the susceptibility of the brain to cellular edema and hemorrhage. 15, 20 Baraton et al. reported that changes in serum sodium levels of more than 13 meq l À1 was significantly associated with the development of impaired functional outcomes after adjustment for GA, as well as perinatal and neonatal hospitalization characteristics. 21 Our study showed that changes in serum sodium levels of more than 13 meq l À1 were significantly associated with severe IVH, thereby providing a reasonable explanation for the findings of Baraton et al. Similar to previous studies, 22, 23 our results indicated that males had an increased risk of developing severe IVH. Male preterm infants had higher cerebral blood flow and a higher incidence of blood pressure change as a result of the dysregulation of dopamine, norepinephrine and serotonin levels in an animal study. 22, 23 Both factors contribute to hypoperfusion and reperfusion injuries in premature babies and augment the rupture of involuting germinal matrix vessels, leading to IVH. 24, 25 Fluctuations in the levels of hemoglobin were also associated with severe IVH in our study. Shaver et al. showed that a lower first hematocrit level during the first 24 h of life was correlated with a higher incidence of IVH. Anemia increases cerebral blood flow and leads to hemorrhage; however, it may simply be the consequence of hemorrhage. 26 The association between vaginal delivery and IVH is controversial. [26] [27] [28] [29] [30] In this case-control study, we found that vaginal delivery was a risk factor for severe IVH. Low superior vena cava flow, resulting from the inability of the immature heart to withstand high systemic resistance after birth, is associated with an increased risk of late IVH. 30, 31 As the majority of hemorrhages develop after the improvement of the superior vena cava flow, hypoperfusion-reperfusion injury was assumed to be the cause of late IVH. In contrast, normal superior vena cava flow was observed among babies with early IVH; hence, it is believed that the hypoperfusion-reperfusion cycle occurred earlier. The association of early IVH with active labor and vaginal delivery suggested that the injury occurred during the intrapartum period.
Although we attempted to eliminate potential confounding variables by using a case-control design in our study, several confounders still existed. Antenatal steroids were more common in the control group of this study (47.2 vs 63.9%; P ¼ 0.236), but it failed to reach statistical significance. The effectiveness of antenatal steroids is affected by their dosage and timing; also, a complete course of antenatal steroids is more effective. As we defined antenatal steroids as any dose of betamethasone or dexamethasone at any time interval before delivery, their effects may have been underestimated. 5 Furthermore, our diagnosis of chorioamnionitis relied on chart documentation without histological studies. Clinical diagnoses of chorioamnionitis are somewhat insensitive and may contribute to its low incidence in other studies. Although a histological diagnosis of chorioamnionitis is more accurate and preferred, the association between histological chorioamnionitis and early IVH remains controversial as Sarkar et al. and Rocha et al. failed to confirm the association between histological chorioamnionitis and IVH. 32, 33 Further studies are required to elucidate the effect of chorioamnionitis on IVH.
Although our study is limited by its relative small sample size and retrospective nature, we showed a significant association between hypernatremia and severe IVH. In addition, hemoglobin fluctuations, vaginal delivery, male sex and sodium fluctuations were associated with an increased risk of severe IVH. The causal relationship of hypernatremia and severe IVH still needs to be clarified.
